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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S130Fig. 1. Effects of ASCs cultured in transwell on BMSCs. ASC 0.25, 0.50,
0.75, I means that 0.25  105, 0.5  105, 0.75  105, and 1.0  105 ASCs
respectively were cultured in a transwell insert over 105 BMSCs on the
lower well. (A) ALP staining, quantiﬁcation of ALP activity and the ALP
mRNA expression from RT-qPCR after 14 days. (B) Von Kossa staining,
quantiﬁcation of calcium contents after 14 days. All values are shown as
percentages over the control (BMSCs without ASCs). Bar represents mean
 SD, p < 0.05: * signiﬁcantly greater than the control; # signiﬁcantly
lower than the control.
Fig. 2. Effects of ASCs in mixed coculture with BMSCs. The number of
BMSCs is ﬁxed at 1.0  105. “ASC : BMSC ¼ 0.25: 1” means that 0.25  105
ASCs were cocultured with 1.0  105 BMSCs. All values are shown as
percentages over the control (BMSCs without ASCs). (a) ALP activity (b)
Calcium contents (c) RT-qPCR for osteogenic markers (d) ELISA for
osteogenic markers after 14 days. Bar represents mean  SD. N ¼ 3 for all
panels. p < 0.05, *signiﬁcantly greater than the control; # signiﬁcantly
lower than the control.204
MEAN ARTERIAL PRESSURE ASSOCIATES WITH UNCOUPLED
REMODELING OF SUBCHONDRAL BONE IN PATIENTS WITH KNEE
OSTEOARTHRITIS
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Degeneration, Shenzhen Inst.s of Advanced Technology, CAS, Shenzhen,
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Purpose: Hypertension frequently coexists with knee osteoarthritis
(OA), and high blood pressure was proven to be a predictor of bone loss.
Our previous animal model study found that high concentration of TGF-
b1 induced formation of mesenchymal stem cells (MSCs) clusters,
leading to uncoupled bone remodeling in subchondral bone and
inducing pathological development of OA. This study investigates
whether the level of mean arterial pressure (MAP) is correlated with the
extent of TGF-b1 signaling and subchondral bone remodeling in knee
OA patients.
Methods: A total of 70 patients undergoing arthroplasty surgery for
primary OA were recruited and divided into two groups according to
their pre-operative MAP: normal (n ¼ 33) or elevated (n ¼ 37). The
patients’ preoperative clinical and radiological evaluations were recor-
ded. The tibial plateau were collected during the operation and pro-
cessed for evaluation using micro-CT and histology. Biomarkers of MSC
(Nestin), osteoclast (Trap), osteoblast (Osterix and Osteocalcin), and
TGF-b1 signaling (pSMAD2/3) were detected using
immunohistochemistry.
Results: There were no signiﬁcant differences of age, body mass index
(BMI) or mechanical alignment detected between the two groups.
Patients with elevated MAP presented lower fraction of bone volume
(BV/TV) (30.71  4.78%) and trabecular number (Tb.N) (1.88  0.42) of
medial subchondral bone compared with those of normal MAP (BV/TV:
36.97 7.51%, p¼ 0.005; Tb.N: 2.25  0.47, p¼ 0.013), yet higher BV/TV
(21.24  4.10%) and Tb.N (1.40  0.33) of lateral side compared with
those of normal MAP (BV/TV: 17.76  4.05%, p ¼ 0.004; Tb.N: 1.22 
0.23, p ¼ 0.02) and the correlation of MAP with BV/TV and Tb.N still
exits after adjusting for age, sex, BMI and mechanical alignment (p <
0.05). Histologically, the elevated MAP group showed higher OARSI
scores of both medial(23.2  1.8) and lateral(10.0  1.9) side than the
normal MAP group(medial 21.6  0.9, p ¼ 0.081;lateral 6.2  1.3, p ¼
0.001). More TRAP positive cells were present in medial subchondral
bone of the elevated MAP group (111  6/ mm z) compared with the
normal MAP group (56  3/mm z, p < 0.05). However, less Nestin (23 
3/mm z), pSMAD2/3 (823  174/mm z), Osterix (208  33/mm z) and
Osteocalcin (31  4/B.Pm) positive cells were observed on the medial
side of elevated MAP group compared with the normal MAP group
(Nestin: 31  4/mm z, p < 0.05; pSMAD2/3: 995  214/mm z, p < 0.05;
Osterix: 247  54/mm z, p < 0.05; Osteocalcin: 42  5/B.Pm, p < 0.05),
which is on the contrary to the changes on the lateral side.
Conclusions: Our data show that elevated MAP is associated with
uncoupled remodeling of subchondral bone in patients with advanced
knee OA, indicated by paradoxical changes of bone between the medial
and lateral side. Furthermore, uneven local recruitment of MSCs in
subchondral bonemediated by TGF-b1 signalingmay be involved in this
pathological development. These ﬁndings provide a possible underlying
mechanism of the association between hypertension and pathological
development of OA, and might guide us to more individualized OA
treatment.
205
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Purpose: Heterotopic ossiﬁcation (HO) is one of the most common
complications after joint surgery and can compromise outcomes of
patients. HO is deﬁned as the formation of ectopic bone in soft tissue
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ferentiation of osteogenic progenitors within skeletal muscle. However
the precise origin of HO is still unclear. Skeletal muscle contains two
kinds of progenitor cells, myogenic progenitors and mesenchymal
progenitors. We have identiﬁed PDGFRaþ mesenchymal progenitors in
mouse muscle interstitium and the PDGFRaþ mesenchymal progeni-
tors showed osteogenic differentiation in response to BMP stimulation,
while another report showed that these cells did not differentiate into
osteogenic cells when stimulated with dexamethasone, b-glycer-
ophosphate and ascorbic acid. These results suggest that HO may be
derived from PDGFRaþ progenitors in skeletal muscle. The purpose of
this study is to examine the localization of PDGFRaþ mesenchymal
progenitors in human HO and bone forming capacity of human skeletal
muscle-derived progenitors in vitro and vivo.
Methods: Immunohistological staining of human HO: HO sample
was obtained by thirty ﬁve-year-old manwho had femoral fracture and
subarachnoid hemorrhage by trafﬁc accident and was treated by open
reduction and internal ﬁxation. X-ray analysis showed that HO was
observed around the left hip joint, especially in rectus femoris muscle
and vastus medialis muscle. We examined human skeletal muscle
sample with HO using immunohistological staining. Osteogenic dif-
ferentiation potential of human skeletal muscle-derived progeni-
tors in vitro: In this study, we used the human muscular tissue of
patients with osteoarthritis of hip, after informed consent was obtained
at the time of hip surgery from ten patients. Experiments using human
samples were approved by the Ethical Review Board for Clinical Studies
at Fujita Health University. Trimmedmuscles wereminced and digested
with 0.2% type II collagenase for 30 min at 37C. After enzymatic
digestion of human skeletal muscle, CD56þ cells and PDGFRaþ cells
were isolated by using ﬂow cytometry. Cells were seeded at a density of
4.2 x 10x cells/cm z and incubated at 37C in 5% CO2 and 21% O2. At 50–
70% conﬂuency, osteogenesis was induced using osteogenic differ-
entiation medium consisting of 10% FBS-aMEM supplemented with
dexamethasone, ascorbate-phosphate, and b-glycerophosphate. The
judgement of osteogenesis was alkaline phosphatase (ALP) staining and
alizarin red S staining. Bone forming capacity of human skeletal
muscle-derived progenitors in vivo: To study the capacity of human
skeletal muscle-derived cells to form bone, cells (1 x 106 cells/ block)
were loaded onto PLGA- hydroxyapatite composite blocks. Implants
were removed after 8 weeks and ﬁxed with 10% formaldehyde, then
embedded in parafﬁn stained using hematoxylin-eosin staining and
immune staining.
Results: Immunohistological staining of human HO: At the staining
of HO sample, many PDGFRaþ cells were found in proximity to ectop-
ically formed bone. In contrast, we did not observe CD56þ cells around
ectopic bone. Osteogenic differentiation potential of human skeletal
muscle-derived progenitors in vitro: Both PDGFRaþ cells and CD56þ
cells became positive for ALP at an early stage of differentiation, while
alizarin red S staining of both cell types did not become positive until 14
days after osteogenic induction. There was no signiﬁcant difference
between them. Bone forming capacity of human skeletal muscle-
derived progenitors in vivo: PDGFRaþ cells showed successful
engraftment and had formed bone-like tissue. Structures histologically
resembling medullary cavities were observed, and multinucleated giant
cells detected at the edges of cavities. In contrast, CD56þ cells did not
create such tissues. Many human cells were detected in PDGFRaþ cell
implants, while only a few human cells were detected in CD56þ cell
implants.
Conclusions: PDGFRaþ cells and CD56þ cells showed comparable dif-
ferentiation potential in vitro with similar levels of ALP activity after
osteogenic differentiation. However, PDGFRaþ cells, but not CD56þ
cells, showed superior engraftment and bone-like tissue formation in
the PLGA-hydroxyapatite scaffold-based an in vivo bone formation
model, suggesting that PDGFRaþ mesenchymal progenitors residing
human skeletal muscle are the major origin of HO.
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HYDROLYZED COLLAGEN CONTRIBUTES TO OSTEOBLAST
DIFFERENTIATION IN VITRO AND SUBSEQUENT BONE HEALTH IN
VIVO
A. Daneault. Inst. Natl. de Recherche Agronomique, St Genes Champanelle,
France
Purpose: Collagen I is the main component of organic bone matrix. Its
correct synthesis, folding and degradation are crucial for bonehomeostasis. According to this pivotal role in bone structure, we
investigated the potential health beneﬁts of hydrolyzed collagen (HC)
on bone using translational approaches.
Methods & Results: Regarding the inﬂuence of HC on bone forming
cells in vitro, we ﬁrst insured the absence of cytotoxicity of HC addition
in culture media. Consistently, as compared to BSA control conditions,
HC even promoted pre-osteoblast proliferation. Then, cells were tested
for differentiation parameters in the presence of HC. HC from bovine
origin resulted in a signiﬁcantly higher alkaline phosphatase activity
after 7 days of incubation when compared to its BSA control condition.
This observation was supported by mineralization assays demonstrat-
ing that bovine HC enhanced Ca/P nodule formation in MC3T3-E1 cul-
tures. To conﬁrm these encouraging results, C3H/HeN mice were
ovariectomized (OVX) to induce bone loss and were given, in parallel,
HC enriched diets to determine whether HC intake may contribute to
bone health by preventing decrease in bone mineral density upon OVX.
Diets were designed to contain 15% casein, 17.5% casein or 15% casein
plus 2.5% HC from bovine origin.
Conclusion: As expected, OVX induced a dramatic loss of bone mineral
density. However, HC fed OVX mice exhibited a signiﬁcant higher BMD
than OVX control mice suggesting a nutritional protective effect of HC,
conﬁrming previous results and further supporting its potential bene-
ﬁts on bone health.Cartilage Biology
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IL18 IS SECRETED UPON JOINT INJURY AND IS A KEY PATHOGENIC
CYTOKINE IN MURINE OSTEOARTHRITIS
T.L. Vincent, A. Chanalaris, J. Zarebska, S. Bullers, B. Stott, A. Burleigh,
E. Paterson, F.E. Watt, J. Saklatvala. Kennedy Inst. of Rheumatology,
Oxford, United Kingdom
Purpose: Osteoarthritis requires the expression and activation of
matrix proteases that drive the degradation of the articular cartilage.
Speciﬁcally these include the aggrecanases, members of the a dis-
integrin and metalloproteinase with thrombospondin motif (ADAMTS)
family, and the collagenases, principally matrix metalloproteinases 1
and 13. IL1 is a potent inducer of ADAMTSes andMMPs in vitro, but little
evidence exists to support its role in disease in vivo. MyD88 is an
essential upstream component of the IL1 receptor (IL1R) signaling
complex, and is also utilized by other IL1R family members such as
IL18R and IL33R, and by several of the Toll like receptors (TLRs 1, 2, 4-9).
We sought to determine the MyD88-dependence of murine OA.
Methods: We investigated the role of IL1 and related cytokines in vivo
by inducing OA in mice (by destabilization of the medial meniscus,
DMM) in which the adapter protein, MyD88, or the ligands/receptors
utilising MyD88, had been deleted. Gene expression proﬁles of wild
type and knockout joints were examined 6h post surgical joint desta-
bilization. Porcine cartilage and synovium were assayed for IL18
secretion following injury in the presence or absence of the caspase
(IL18-processing enzyme) inhibitor, Z-VAD-FMK. For in vivo experi-
ments, Z-VAD-FMK was injected into wild type mice every two days
prior to (for 1 week) and following DMM surgery for a further 4 weeks.
Joints were sectioned and scored histologically. For human studies,
control synovial ﬂuid or that taken from individuals who had recently
sustained acute destabilizing injuries to the joint (largely meniscal and
cruciate ligament) were assayed for IL18 using an MBL ELISA (Nagoya,
Japan).
Results: MyD88 -/- mice were strongly protected from surgically
induced OA at 4, 8 and 12 weeks post surgery. Of the other knockout
mice tested (IL1 receptor, TLR2, TLR4, TLR7, IL33R, IL18), only IL18-/-
mice phenocopied the protection seen in MyD88-/- mice. No change
in gene expression for IL18, its receptor or the endogenous negative
regulator, IL18 binding protein, was measured in destabilized joints,
but IL18 protein was secreted by porcine synovium in vitro following
explantation injury in a caspase-dependent manner. Gene expression
in IL18-/- joints following DMM showed several genes were altered
compared to wild type joints indicating that there are IL18-depend-
ent changes in gene expression upon induction of OA. Mice treated
with the caspase inhibitor, Z-VAD-FMK showed a signiﬁcant reduc-
tion in disease severity 4 weeks post DMM compared to vehicle
treated mice. Of the human studies, IL18 was signiﬁcantly elevated in
the synovial ﬂuid of patients following acute joint injury compared to
controls.
